Back
Structure Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
GPCR
Structure Therapeutics, Inc.
Last Price:
$63.14
Seasonality Move:
11.23%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.
Structure Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.9 | Sell |
| 20-day SMA: | 72.28 | Sell |
| 50-day SMA: | 74.44 | Sell |
| 200-day SMA: | 38.32 | Buy |
| 8-day EMA: | 66.07 | Sell |
| 20-day EMA: | 70.66 | Sell |
| 50-day EMA: | 69.27 | Sell |
| 200-day EMA: | 47.25 | Buy |
Structure Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.58 | Sell |
| Relative Strength Index (14 RSI): | 33.4 | Sell |
| Chaikin Money Flow: | -14170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.42 - 84.72) | Sell |
| Bollinger Bands (100): | (33.67 - 77.57) | Buy |
Structure Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics, Inc. Stock
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 62.90 while GPCR 8-day simple moving average is 65.90, which is a Sell signal.
-
The stock price of GPCR is 62.90 while Structure Therapeutics, Inc. 20-day SMA is 72.28, which makes it a Sell.
-
Structure Therapeutics, Inc. 50-day simple moving average is 74.44 while GPCR share price is 62.90, making it a Sell technically.
-
GPCR stock price is 62.90 and Structure Therapeutics, Inc. 200-day simple moving average is 38.32, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
43
Structure Therapeutics, Inc. (GPCR)
is a Sell
Is Structure Therapeutics, Inc. a Buy or a Sell?
-
Structure Therapeutics, Inc. stock is rated a SellThe current Structure Therapeutics, Inc. [GPCR] share price is $62.90. The Score for GPCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics, Inc. Stock Info
Market Cap:
4.4B
Price in USD:
62.90
Share Volume:
518.5K
Structure Therapeutics, Inc. 52-Week Range
52-Week High:
94.90
52-Week Low:
13.22
Sell
43
Structure Therapeutics, Inc. (GPCR)
is a Sell
Structure Therapeutics, Inc. Share Price Forecast
-
What is the Structure Therapeutics, Inc. stock price today?The Structure Therapeutics, Inc. stock price is 62.90 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics, Inc. is overvalued.
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 62.90 while GPCR 8-day exponential moving average is 66.07, which is a Sell signal.
-
The stock price of GPCR is 62.90 while Structure Therapeutics, Inc. 20-day EMA is 70.66, which makes it a Sell.
-
Structure Therapeutics, Inc. 50-day exponential moving average is 69.27 while GPCR share price is 62.90, making it a Sell technically.
-
GPCR stock price is 62.90 and Structure Therapeutics, Inc. 200-day simple moving average is 47.25, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics, Inc.
Is Structure Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Structure Therapeutics, Inc.
Should I short Structure Therapeutics, Inc. stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is -3.58, suggesting Structure Therapeutics, Inc. is a Sell
-
Structure Therapeutics, Inc. Relative Strength Index (RSI) is 33.4, which suggest Structure Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Structure Therapeutics, Inc. is (66.42 - 84.72), which suggest Structure Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics, Inc. is (33.67 - 77.57), which suggest Structure Therapeutics, Inc. is a Buy
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.